Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Nuvotronics (United States) | Researchclopedia

Back to institutions

Nuvotronics (United States)

Radford, Virginiacompany

73

Works

1,512

Citations

20

h-index

Top Research Topics

Microwave Engineering and Waveguides Antenna Design and Analysis Advanced Antenna and Metasurface Technologies

Top Researchers

K. W. Bowman Jet Propulsion Laboratory

655 works18,303 citationsh-index: 74

Recent Research

53P Characterization of the safety profile of taletrectinib in patients with advanced ROS1+ non-small cell lung cancer (NSCLC): Results from TRUST-I and TRUST-II

Y.Y. Elamin,S. Owen,et al.

20260 citations

Radio Frequency Integrated Circuit Design

3D IC and TSV technologies

Lung Cancer Treatments and Mutations

Electromagnetic Compatibility and Noise Suppression

Soil Moisture and Remote Sensing

Antenna Design and Optimization

Photonic and Optical Devices

Silicon Carbide Semiconductor Technologies

Advanced MEMS and NEMS Technologies

Zhiqiang Hu Sun Yat-sen University

363 works10,183 citationsh-index: 45

214 works9,915 citationsh-index: 39

Carlos Eduardo de Rezende State University of Norte Fluminense

347 works7,743 citationsh-index: 47

Gary Hattersley Nuvotronics (United States)

105 works5,327 citationsh-index: 35

Peter T. May Australian Regenerative Medicine Institute

190 works5,008 citationsh-index: 45

CTNI-19. PHASE 2, MULTICENTER, RANDOMIZED CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SAFUSIDENIB IN PATIENTS WITH HIGH-GRADE ISOCITRATE DEHYDROGENASE 1 (IDH1)-MUTANT GLIOMA

David A. Reardon,Yoshie Umemura,et al.

20250 citations

MA02.02 Updated Efficacy and Safety of Taletrectinib in Patients With ROS1+ Non-Small Cell Lung Cancer: The Global TRUST-II Study

Geoffrey Liu,C.-M. Choi,et al.

20252 citations

P3.12.04 Taletrectinib, a Next Generation Selective ROS1 Inhibitor, Exhibits a Differentiated Profile in ROS1 Fusion Models

Hardik Patel,Loreé C. Heller,et al.

20250 citations

P3.12.69 Updated Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: Phase 2 TRUST-I Study

Wei Li,A. Xiong,et al.

20251 citations

P3.12.12 Clinical Pharmacologic Characteristics of Taletrectinib

M. Pérol,Nathan A. Pennell,et al.

20250 citations